291 related articles for article (PubMed ID: 32352599)
1. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
[TBL] [Abstract][Full Text] [Related]
3. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine pathway changes in late-life depression.
Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
[TBL] [Abstract][Full Text] [Related]
5. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17():47. PubMed ID: 27130315
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
[TBL] [Abstract][Full Text] [Related]
7. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
[TBL] [Abstract][Full Text] [Related]
8. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine, sICAM-1 and Kynurenine Pathway in Restrictive Anorexia Nervosa-Exploratory Study.
Dudzińska E; Szymona K; Kloc R; Kocki T; Gil-Kulik P; Bogucki J; Kocki J; Paduch R; Urbańska EM
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498837
[TBL] [Abstract][Full Text] [Related]
10. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity.
Vidal R; García-Marchena N; O'Shea E; Requena-Ocaña N; Flores-López M; Araos P; Serrano A; Suárez J; Rubio G; Rodríguez de Fonseca F; Colado MI; Pavón FJ
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109958. PubMed ID: 32360814
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection.
Xiang ZY; Tang AG; Ren YP; Zhou QX; Luo XB
Clin Chem Lab Med; 2010 Apr; 48(4):513-7. PubMed ID: 20187853
[TBL] [Abstract][Full Text] [Related]
12. A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma.
Arnhard K; Pitterl F; Sperner-Unterweger B; Fuchs D; Koal T; Oberacher H
Electrophoresis; 2018 May; 39(9-10):1171-1180. PubMed ID: 29327354
[TBL] [Abstract][Full Text] [Related]
13. The immune-kynurenine pathway in social anxiety disorder.
Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
[TBL] [Abstract][Full Text] [Related]
14. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
[TBL] [Abstract][Full Text] [Related]
15. Optimization of Zn2+-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by high performance liquid chromatography.
Zhao J; Gao P; Zhu D
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(5-6):603-8. PubMed ID: 20102795
[TBL] [Abstract][Full Text] [Related]
16. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
17. Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
Cihan M; Doğan Ö; Ceran Serdar C; Altunçekiç Yıldırım A; Kurt C; Serdar MA
J Clin Lab Anal; 2022 Mar; 36(3):e24257. PubMed ID: 35092710
[TBL] [Abstract][Full Text] [Related]
18. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings.
Noyan H; Erdağ E; Tüzün E; Yaylım İ; Küçükhüseyin Ö; Hakan MT; Gülöksüz S; Rutten BPF; Saka MC; Atbaşoğlu C; Alptekin K; van Os J; Üçok A
Schizophr Res; 2021 Mar; 229():27-37. PubMed ID: 33609988
[TBL] [Abstract][Full Text] [Related]
19. LC-MS/MS-based quantification of tryptophan, kynurenine, and kynurenic acid in human placental, fetal membranes, and umbilical cord samples.
Pedraz-Petrozzi B; Marszalek-Grabska M; Kozub A; Szalaj K; Trzpil A; Stachniuk A; Lamadé EK; Gilles M; Deuschle M; Turski WA; Fornal E
Sci Rep; 2023 Aug; 13(1):12554. PubMed ID: 37532780
[TBL] [Abstract][Full Text] [Related]
20. Low Serum Tryptophan Levels as an Indicator of Global Cognitive Performance in Nondemented Women over 50 Years of Age.
Ramos-Chávez LA; Roldán-Roldán G; García-Juárez B; González-Esquivel D; Pérez de la Cruz G; Pineda B; Ramírez-Ortega D; García Muñoz I; Jiménez Herrera B; Ríos C; Gómez-Manzo S; Marcial-Quino J; Sánchez Chapul L; Carrillo Mora P; Pérez de la Cruz V
Oxid Med Cell Longev; 2018; 2018():8604718. PubMed ID: 30584466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
